Top Markets
Coin of the day
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
Kedudukan dalam Saham #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Harga Saham
$26.13
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$873.45M
Perubahan (1 hari)
-2.99%
Perubahan (1 tahun)
-
Negara
US
Perdagangan SpyGlass Pharma, Inc. Common Stock (SGP)

Kategori

Nisbah P/S bagi SpyGlass Pharma, Inc. Common Stock (SGP)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini SpyGlass Pharma, Inc. Common Stock, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk SpyGlass Pharma, Inc. Common Stock dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH